KMTS · Kestra Medical Technologies, Ltd.
$21.01
-0.56 (-2.60%)
At close · Jul 24
Market Cap
$1.23B
Shares
58.60M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$21.57
Open$20.43
Day$20.40–21.57
52W$14.10–30.00
Avg vol 30d438K
Short int3.1M · 5.3% float · 6.1d
Short vol80%
Last earningsJul 14, 2026
DataMar 2025–Jul 2026
Filing10-K · Jul 14
Up next
Next earnings call
Oct 16, 2026
Est · unconfirmed
· in 12 wks
FQ1-27 quarter ends
~Jul 30, 2026
Est
filed Jul 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−8%
below
Price vs 50-day avg
−3%
below
RSI (14)
41
neutral
MACD trend
Negative
52-week position
47%
mid-range
Momentum
relative strength
1-month return
−2%
trailing
6-month return
−13%
trailing
YTD return
−19%
this year
Relative strength
−19%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $22 › 200d $24 — 200d above 50d
Institutional flow
Accumulating
14 of 102 funds reported for Jun 30 · net +57.6K sh shares · +1 new
Insider flow
Distributing
Net -$314.3K over 90 days · 100% sells
Short interest
Falling
5.28% of float · ▼ -7.9% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
102 holders — mid 1-yr range
Squeeze score
58
elevated · 0–100
Fundamentals
Revenue growth
+59%
Y/Y
Gross margin
51%
expanding
EPS growth
+53%
Y/Y
Free cash flow
$-116.6M
Balance sheet
$57.1M
net cash
Quant / Vol
risk profile
Volatility
64%
annualized · 1-yr
Max drawdown
−36%
past year
ATR
7.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 14, 2026
Revenue
· FY27
Initiated
$137M
prior FY $95.13M
midpoint +44.0% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−8%
Bearish
Price vs 50-day avg
−3%
Neutral
RSI (14)
41
Neutral
MACD trend
Negative
Bearish
52-week position
47%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $22 › 200d $24 — 200d above 50d
Institutional flow
Accumulating
14 of 102 funds reported for Jun 30 · net +57.6K sh shares · +1 new
Insider flow
Distributing
Net -$314.3K over 90 days · 100% sells
Short interest
Falling
5.28% of float · ▼ -7.9% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
102 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $14
Now $22 · 47%
52-wk high $30
vs 200-day avg -8%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| prescriptions were written for the ASSURE® system | 6,357 | Q4 FY2026 | — |
|
|
|||
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KMTS
this stock
Kestra Medical Technologies, Ltd.
|
$1.23B | -18.7% | +59.0% | — | 5.3% |
|
ISRG
Intuitive Surgical Inc
|
$119.23B | -41.4% | +20.5% | 38.8 | 1.9% |
|
MDLN
Medline Inc.
|
$50.91B | -7.7% | +11.5% | — | 2.2% |
|
BDX
Becton Dickinson & Co
|
$43.08B | +1.6% | +8.2% | 59.4 | 3.8% |
|
ALC
Alcon Inc
|
$33.12B | -14.7% | +10.5% | — | 2.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KMTS | -10.1% | -2.3% | -13.1% | -15.2% | -18.7% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -8.4% | -3.0% | -19.5% | -14.1% | -26.9% |
Key facts
CIK
1877184
CUSIP
G52441105
13F (30d)
12 filings
12 filers
Visit website
Investor relations